During the last session, HCW Biologics Inc (NASDAQ:HCWB)’s traded shares were 3.85 million, with the beta value of the company hitting 1.20. At the end of the trading day, the stock’s price was $0.71, reflecting an intraday loss of -25.08% or -$0.24. The 52-week high for the HCWB share is $2.52, that puts it down -254.93 from that peak though still a striking 60.56% gain since the share price plummeted to a 52-week low of $0.28. The company’s market capitalization is $26.84M, and the average intraday trading volume over the past 10 days was 57.18 million shares, and the average trade volume was 8.82 million shares over the past three months.
HCW Biologics Inc (NASDAQ:HCWB) trade information
HCW Biologics Inc (HCWB) registered a -25.08% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -25.08% in intraday trading to $0.71, hitting a weekly high. The stock’s 5-day price performance is 129.64%, and it has moved by 39.14% in 30 days. Based on these gigs, the overall price performance for the year is -33.06%. The short interest in HCW Biologics Inc (NASDAQ:HCWB) is 8092.0 shares and it means that shorts have 0.28 day(s) to cover.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
HCW Biologics Inc (HCWB) estimates and forecasts
In the rating firms’ projections, revenue will decrease -60.34% compared to the previous financial year.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -34.57%.
HCWB Dividends
HCW Biologics Inc is due to release its next quarterly earnings in December. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
HCW Biologics Inc (NASDAQ:HCWB)’s Major holders
HCW Biologics Inc insiders own 52.30% of total outstanding shares while institutional holders control 3.13%, with the float percentage being 6.56%. AVANTAX PLANNING PARTNERS, INC. is the largest shareholder of the company, while 18.0 institutions own stock in it. As of 2024-06-30, the company held over 0.28 million shares (or 0.751% of all shares), a total value of $0.18 million in shares.
The next largest institutional holding, with 0.18 million shares, is of HIGHTOWER ADVISORS, LLC’s that is approximately 0.4857% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $0.12 million.
